Development and characterization of a unique anti‐IgE mouse monoclonal antibody cross‐reactive between human and canine IgE
Abstract Background The efficacy assessment of human anti‐IgE monoclonal antibodies (mAbs) in animal models before clinical trials is hampered due to the lack of cross‐reactivity of anti‐IgE mAbs between species. Objective We developed CRE‐DR (an anti‐dog IgE monoclonal antibody), an anti‐IgE mouse...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Wiley
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/93d9387f9b0442d697cdbaa8d8f1660e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|